These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10695710)

  • 41. Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients.
    de Bruyn A; Poesen K; Bossuyt X; Heremans IP; Claeys T; Depuydt CE; Van Damme P; Claeys KG
    Acta Neurol Belg; 2019 Mar; 119(1):29-36. PubMed ID: 30747336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
    Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
    Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
    Yuki N; Koga M; Hirata K
    Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barré syndrome.
    Dilley A; Gregson NA; Hadden RD; Smith KJ
    J Neuroimmunol; 2003 Jun; 139(1-2):133-40. PubMed ID: 12799030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
    Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
    Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fine specificity of anti-GQ1b IgG and clinical features.
    Susuki K; Yuki N; Hirata K
    J Neurol Sci; 2001 Mar; 185(1):5-9. PubMed ID: 11266684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome.
    Jacobs BC; Endtz H; van der Meché FG; Hazenberg MP; Achtereekte HA; van Doorn PA
    Ann Neurol; 1995 Feb; 37(2):260-4. PubMed ID: 7531419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-LM1 antibodies in the sera of patients with Guillain-Barré syndrome, Miller Fisher syndrome, and motor neuron disease.
    Harukawa H; Utsumi H; Asano A; Yoshino H
    J Peripher Nerv Syst; 2002 Mar; 7(1):54-8. PubMed ID: 11939352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers.
    Koga M; Gilbert M; Takahashi M; Li J; Hirata K; Kanda T; Yuki N
    J Neurol; 2012 Jul; 259(7):1366-74. PubMed ID: 22218648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuro-ophthalmology and the Anti-GQ1b antibody syndromes.
    Saul RF
    Curr Neurol Neurosci Rep; 2009 Sep; 9(5):379-83. PubMed ID: 19664367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent developments in Miller Fisher syndrome and related disorders.
    Overell JR; Willison HJ
    Curr Opin Neurol; 2005 Oct; 18(5):562-6. PubMed ID: 16155441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathophysiology of Ataxia in Fisher Syndrome].
    Kuwabara S
    Brain Nerve; 2016 Dec; 68(12):1411-1414. PubMed ID: 27916750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Miller-Fisher syndrome].
    Jørgensen L; Vedeler CA
    Tidsskr Nor Laegeforen; 2005 May; 125(10):1327-8. PubMed ID: 15909003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anti-GD1b IgG positive case of overlapping Ficher's and Guillain-Barré syndromes].
    Caudie C; Schandelong A; Rapoport F; Vial C
    Ann Biol Clin (Paris); 2004; 62(5):591-4. PubMed ID: 15355812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
    Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
    Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum.
    Fukami Y; Wong AH; Funakoshi K; Safri AY; Shahrizaila N; Yuki N
    Eur J Neurol; 2016 Feb; 23(2):320-6. PubMed ID: 26176883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective.
    O'Hanlon GM; Bullens RW; Plomp JJ; Willison HJ
    Neurochem Res; 2002 Aug; 27(7-8):697-709. PubMed ID: 12374204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ataxia with ophthalmoplegia: Miller-Fisher syndrome with anti-GQ1b antibody positivity].
    Guilloton L; Camarasa C; Agard E; Tondeur G; Dot C; Drouet A
    J Fr Ophtalmol; 2014 Feb; 37(2):89-92. PubMed ID: 24513384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute onset of a bilateral areflexical mydriasis in Miller-Fisher syndrome: a rare neuro-ophthalmologic disease.
    Caccavale A; Mignemi L
    J Neuroophthalmol; 2000 Mar; 20(1):61-2. PubMed ID: 10770512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.